FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder
Fanapt was previously approved by the FDA in 2009 as an antipsychotic treatment for schizophrenia.
October 22, 2026
Fanapt was previously approved by the FDA in 2009 as an antipsychotic treatment for schizophrenia.